CGON
Cg Oncology Inc.

475
Mkt Cap
$3.37B
Volume
6.00
52W High
$46.01
52W Low
$14.80
PE Ratio
-20.97
CGON Fundamentals
Price
$41.61
Prev Close
$41.74
Open
$42.50
50D MA
$41.89
Beta
1.60
Avg. Volume
887,918.26
EPS (Annual)
-$1.16
P/B
4.74
Rev/Employee
$10,079.65
Loading...
Loading...
News
all
press releases
CG Oncology (NASDAQ:CGON) Earns Outperform Rating from Analysts at Wedbush
Wedbush started coverage on CG Oncology in a research report on Thursday. They set an "outperform" rating and a $70.00 price objective for the company...
MarketBeat·21h ago
News Placeholder
More News
News Placeholder
CG Oncology (NASDAQ:CGON) Sets New 1-Year High - Still a Buy?
CG Oncology (NASDAQ:CGON) Hits New 12-Month High - Should You Buy...
MarketBeat·6d ago
News Placeholder
Schroder Investment Management Group Acquires 155,737 Shares of CG Oncology, Inc. $CGON
Schroder Investment Management Group boosted its stake in shares of CG Oncology, Inc. (NASDAQ:CGON - Free Report) by 143.8% in the second quarter, according to the company in its most recent Form 13F...
MarketBeat·7d ago
News Placeholder
FY2025 EPS Estimates for CG Oncology Increased by Analyst
CG Oncology, Inc. (NASDAQ:CGON - Free Report) - Stock analysts at Lifesci Capital lifted their FY2025 earnings per share (EPS) estimates for shares of CG Oncology in a research report issued to...
MarketBeat·11d ago
News Placeholder
CG Oncology, Inc. $CGON Shares Purchased by Franklin Resources Inc.
Franklin Resources Inc. grew its stake in shares of CG Oncology, Inc. (NASDAQ:CGON - Free Report) by 12.7% in the second quarter, according to its most recent filing with the SEC. The fund owned...
MarketBeat·14d ago
News Placeholder
CG Oncology (NASDAQ:CGON) Reaches New 12-Month High - Here's What Happened
CG Oncology (NASDAQ:CGON) Reaches New 1-Year High - Still a Buy...
MarketBeat·15d ago
News Placeholder
Ensign Peak Advisors Inc Has $10.31 Million Stock Holdings in CG Oncology, Inc. $CGON
Ensign Peak Advisors Inc lifted its holdings in shares of CG Oncology, Inc. (NASDAQ:CGON - Free Report) by 195.0% during the 2nd quarter, according to the company in its most recent filing with the...
MarketBeat·18d ago
News Placeholder
15,758 Shares in CG Oncology, Inc. $CGON Bought by Neo Ivy Capital Management
Neo Ivy Capital Management acquired a new stake in shares of CG Oncology, Inc. (NASDAQ:CGON - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the...
MarketBeat·19d ago
News Placeholder
CenterBook Partners LP Acquires 56,971 Shares of CG Oncology, Inc. $CGON
CenterBook Partners LP increased its holdings in CG Oncology, Inc. (NASDAQ:CGON - Free Report) by 28.0% during the 2nd quarter, according to the company in its most recent disclosure with the...
MarketBeat·19d ago
News Placeholder
FY2026 EPS Estimates for CG Oncology Increased by Analyst
CG Oncology, Inc. (NASDAQ:CGON - Free Report) - Equities research analysts at Cantor Fitzgerald raised their FY2026 earnings per share estimates for shares of CG Oncology in a research note issued on...
MarketBeat·22d ago

Latest CGON News

View

Advertisement|Remove ads.

Advertisement|Remove ads.